CEO Interviews

ElevateBio CEO on disruptive potential for gene and cell therapies

David Hallal, ElevateBio CEO, joins 'Fast Money' to talk making CNBC's Disruptor 50 list, what is included in its portfolio, innovation in cell and gene therapy and more.

adminadmin
May 15, 2024 - 23:18
 0  5
ElevateBio CEO on disruptive potential for gene and cell therapies
David Hallal, ElevateBio CEO, joins 'Fast Money' to talk making CNBC's Disruptor 50 list, what is included in its portfolio, innovation in cell and gene therapy and more.
Read More

Tags:

Previous Article

Stanley Black & Decker CEO Donald Allan Jr. goes one-on-one with Jim Cramer

Next Article

Alphabet CEO on report OpenAI trained GPT-4 on YouTube: We have clear terms of s...

admin
admin

Related Posts

Consumers are very focused on value, says HundredX CEO Rob Pace

Consumers are very focused on value, says HundredX CEO ...

admin Jul 17, 2024  0  17

Perplexity CEO on 'Internal Knowledge' AI search, AI race and competition

Perplexity CEO on 'Internal Knowledge' AI search, AI ra...

admin Oct 18, 2024  0  8

GE Aerospace CEO Larry Culp on supply chain challenges

GE Aerospace CEO Larry Culp on supply chain challenges

admin Sep 11, 2024  0  19